© 2025 Abbott Laboratories. All Rights Reserved. Please read the Legal Notice for further details. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott tradema...
Abbott Laboratories stock outperforms competitors on strong trading day Jan. 16, 2025 at 4:34 p.m. ET by MarketWatch Automation Abbott Laboratories stock underperforms Wednesday when compared to competitors Jan. 15, 2025 at 4:33 p.m. ET by MarketWatch Automation Abbott Laboratories stock...
heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888...
Abbott Laboratories (ABT) Q4 2023 Earnings Call Transcript ABT earnings call for the period ending December 31, 2023. Motley Fool Transcribing | Jan 24, 2024 Related Stocks NASDAQ: ISRG Intuitive Surgical Market Cap $215B Current Price $604.12 ...
Abbott Laboratories's advanced charting and technical analysis tool lets you customize your analysis with a wide range of studies and indicators, including Moving Averages (SMA and EMA), MACD, On-Balance Volume, Relative Strength Index (RSI), Bollinger Bands, Fibonacci Lines, and more. You can...
Abbott Laboratories (ABT) Frequently Asked QuestionsPeople Also Follow SymbolLast PriceChange MDTMedtronic plc 88.38 Pre. 88.15 0.34% -0.26% ABBVAbbVie Inc. 172.61 Pre. 171.57 0.61% -0.60% JNJJohnson & Johnson 148.15 Pre. 144.47 0.76% -2.48% MRKMerck & Co., Inc. 96.24 Pre. 96.01 -...
Abbott Laboratories stock performance at a glance Check Abbott Laboratories’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. ABT Stock Performance Previous close 114.25 Day range 111.79 - 113.84 Year range 99 - 121 Market...
RBC Capital Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $135 Futu NewsJan 8 10:32· Ratings Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst BenzingaJan 8 03:45 Wells Fargo Sticks to Their Buy Ratin...
Get Abbott Laboratories (ABT:NYSE) real-time stock quotes, news, price and financial information from CNBC.
Abbott Laboratories (ABL) has a Smart Score of 10 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.